Medicover AB (publ) (LON:0RPS)
London
· Delayed Price · Currency is GBP · Price in SEK 206.50
+5.00 (2.48%)
Feb 21, 2025, 1:02 PM BST
Medicover AB Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 2,092 | 1,746 | 1,510 | 1,377 | 997.8 | Upgrade
|
| Revenue Growth (YoY) | 19.78% | 15.64% | 9.64% | 38.04% | 18.17% | Upgrade
|
| Cost of Revenue | 1,644 | 1,387 | 1,170 | 982.4 | 733.6 | Upgrade
|
| Gross Profit | 448.3 | 359.4 | 340.1 | 395 | 264.2 | Upgrade
|
| Selling, General & Admin | 371.3 | 297.1 | 271.4 | 232.4 | 196.2 | Upgrade
|
| Operating Expenses | 371.3 | 297.1 | 271.4 | 232.4 | 196.2 | Upgrade
|
| Operating Income | 77 | 62.3 | 68.7 | 162.6 | 68 | Upgrade
|
| Interest Expense | -58.8 | -51.4 | -34.5 | -20.1 | -18.1 | Upgrade
|
| Interest & Investment Income | 4.8 | 4.4 | 2.7 | 1 | 0.9 | Upgrade
|
| Earnings From Equity Investments | - | 0.1 | 0.2 | 1 | 0.1 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.4 | 1.1 | -3.3 | 1.8 | -8.4 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.4 | 0.2 | 2.4 | 0.3 | 0.2 | Upgrade
|
| EBT Excluding Unusual Items | 26.8 | 16.7 | 36.2 | 146.6 | 42.7 | Upgrade
|
| Merger & Restructuring Charges | 0.2 | -0.7 | -7.2 | -3.2 | -1.5 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -3.2 | 0.4 | 1.3 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 7.8 | - | - | - | Upgrade
|
| Asset Writedown | - | -0.2 | -6.3 | - | -5.2 | Upgrade
|
| Other Unusual Items | -6.9 | - | - | - | - | Upgrade
|
| Pretax Income | 20.1 | 23.6 | 19.5 | 143.8 | 37.3 | Upgrade
|
| Income Tax Expense | 5.5 | 5.2 | 5.8 | 37.2 | 10 | Upgrade
|
| Earnings From Continuing Operations | 14.6 | 18.4 | 13.7 | 106.6 | 27.3 | Upgrade
|
| Minority Interest in Earnings | 2.1 | -0.8 | -1.9 | -4.8 | -1.5 | Upgrade
|
| Net Income | 16.7 | 17.6 | 11.8 | 101.8 | 25.8 | Upgrade
|
| Net Income to Common | 16.7 | 17.6 | 11.8 | 101.8 | 25.8 | Upgrade
|
| Net Income Growth | -5.11% | 49.15% | -88.41% | 294.57% | 14.67% | Upgrade
|
| Shares Outstanding (Basic) | 150 | 149 | 149 | 148 | 142 | Upgrade
|
| Shares Outstanding (Diluted) | 150 | 150 | 149 | 148 | 142 | Upgrade
|
| Shares Change (YoY) | 0.36% | 0.47% | 0.41% | 4.66% | 6.31% | Upgrade
|
| EPS (Basic) | 0.11 | 0.12 | 0.08 | 0.69 | 0.18 | Upgrade
|
| EPS (Diluted) | 0.11 | 0.12 | 0.08 | 0.69 | 0.18 | Upgrade
|
| EPS Growth | -5.48% | 49.16% | -88.48% | 276.93% | 8.33% | Upgrade
|
| Free Cash Flow | 139.6 | 94.5 | 29.6 | 114.5 | 82.6 | Upgrade
|
| Free Cash Flow Per Share | 0.93 | 0.63 | 0.20 | 0.77 | 0.58 | Upgrade
|
| Dividend Per Share | 0.150 | 0.120 | 0.120 | 0.120 | 0.070 | Upgrade
|
| Dividend Growth | 25.00% | 0% | 0% | 71.43% | - | Upgrade
|
| Gross Margin | 21.43% | 20.58% | 22.52% | 28.68% | 26.48% | Upgrade
|
| Operating Margin | 3.68% | 3.57% | 4.55% | 11.80% | 6.81% | Upgrade
|
| Profit Margin | 0.80% | 1.01% | 0.78% | 7.39% | 2.59% | Upgrade
|
| Free Cash Flow Margin | 6.67% | 5.41% | 1.96% | 8.31% | 8.28% | Upgrade
|
| EBITDA | 207.5 | 156.3 | 152.7 | 220.6 | 114.4 | Upgrade
|
| EBITDA Margin | 9.92% | 8.95% | 10.11% | 16.02% | 11.47% | Upgrade
|
| D&A For EBITDA | 130.5 | 94 | 84 | 58 | 46.4 | Upgrade
|
| EBIT | 77 | 62.3 | 68.7 | 162.6 | 68 | Upgrade
|
| EBIT Margin | 3.68% | 3.57% | 4.55% | 11.80% | 6.81% | Upgrade
|
| Effective Tax Rate | 27.36% | 22.03% | 29.74% | 25.87% | 26.81% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.